Investing.com - Financial Markets Worldwide

biOasis Technologies Inc (BIOAF)

OTC Markets
Currency in USD
0.000001
0.000000(0.00%)
Closed·
BIOAF Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week Low
BIOAF is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
0.0000010.000001
52 wk Range
0.0000010.000400
Key Statistics
Edit
Prev. Close
0.000001
Open
0.000001
Day's Range
0.000001-0.000001
52 wk Range
0.000001-0.0004
Volume
-
Average Volume (3m)
3.25K
1-Year Change
-99%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOAF Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 9
Suffers from weak gross profit margins
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

biOasis Technologies Inc Company Profile

Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the transport of therapeutic agents across the blood-brain barrier (BBB); and the treatment of central nervous system disorders (CNS), including brain cancers, and metabolic and neurodegenerative diseases. The company’s in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). It has research collaborations with Aposense Limited to focus on the delivery of siRNA therapeutics for CNS disorders; Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane’s OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain; and Janssen Biotech, Inc. to research, develop, and commercialize novel products based on Bioasis’ xB3 platform. The company also has a research collaboration and license agreement with Neuramedy Co Ltd. to research, develop, and commercialize an xB3TM version of its antibody, Tomaralimab. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut.

Industry
Biotechnology & Medical Research
Sector
Healthcare
0
Market
United States

Compare BIOAF to Peers and Sector

Metrics to compare
BIOAF
Peers
Sector
Relationship
P/E Ratio
0.0x−3.0x−0.6x
PEG Ratio
0.000.000.00
Price/Book
0.0x1.5x2.6x
Price / LTM Sales
0.0x8.7x3.3x
Upside (Analyst Target)
0.0%205.1%38.7%
Fair Value Upside
Unlock1.2%5.1%Unlock

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

BIOAF Income Statement

FAQ

What Stock Exchange Does biOasis Tech Inc Trade On?

biOasis Tech Inc is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for biOasis Tech Inc?

The stock symbol for biOasis Tech Inc is "BIOAF."

What Is the biOasis Tech Inc Market Cap?

As of today, biOasis Tech Inc market cap is 79.00.

What Is biOasis Tech Inc's Earnings Per Share (TTM)?

The biOasis Tech Inc EPS (TTM) is -0.04.

When Is the Next biOasis Tech Inc Earnings Date?

biOasis Tech Inc will release its next earnings report on 26 Oct 2025.

From a Technical Analysis Perspective, Is BIOAF a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has biOasis Tech Inc Stock Split?

biOasis Tech Inc has split 0 times.

How Many Employees Does biOasis Tech Inc Have?

biOasis Tech Inc has 0 employees.

What is the current trading status of biOasis Tech Inc (BIOAF)?

As of 28 Aug 2025, biOasis Tech Inc (BIOAF) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.